0001047469-19-001538 Sample Contracts

HOOKIPA PHARMA INC. [FORM OF] DIRECTOR INDEMNIFICATION AGREEMENT
Director Indemnification Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations • Delaware

This Indemnification Agreement (“Agreement”) is made as of [ ] by and between HOOKIPA Pharma Inc., a Delaware corporation (the “Company”), and [Director] (“Indemnitee”).

AutoNDA by SimpleDocs
HOOKIPA PHARMA INC. [FORM OF] OFFICER INDEMNIFICATION AGREEMENT
Officer Indemnification Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations • Delaware

This Indemnification Agreement (“Agreement”) is made as of [ ] by and between Hookipa Pharma Inc., a Delaware corporation (the “Company”), and [Officer] (“Indemnitee”).(1)

RESEARCH COLLABORATION AND LICENSE AGREEMENT BY AND BETWEEN GILEAD SCIENCES, INC. AND HOOKIPA BIOTECH AG
Research Collaboration and License Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations • New York

This RESEARCH COLLABORATION AND LICENSE AGREEMENT (this “Agreement”) is made as of June 4, 2018 (the “Effective Date”), by and between Gilead Sciences, Inc., a Delaware corporation having an office at 333 Lakeside Drive, Foster City, CA 94404 (“Gilead”) and Hookipa Biotech AG, an Austrian corporation (Aktiengesellschaft) having an office at St Marx Vienna Bio Center: Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria (“Hookipa”). Gilead and Hookipa are each referred to individually as a “Party” and together as the “Parties.”

CONSULTANCY AGREEMENT
Consultancy Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
Contract
Exclusive License Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations

CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[***]”. AN UNREDACTED VERSION OF THE DOCUMENT HAS ALSO BEEN FURNISHED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION AS REQUIRED BY RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

Contract
Exclusive License Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations

CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[***]”. AN UNREDACTED VERSION OF THE DOCUMENT HAS ALSO BEEN FURNISHED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION AS REQUIRED BY RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

RENTAL AGREEMENT Partial application area Office
Rental Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations

Concluded between: Wüstenrot Marxbox GmbH & Co KG Alpenstraße 61, 5033 Salzburg FN 346428d represented by ÖRAG - Österreichische Realitäten 1010 Vienna, Herrengasse 17, as the Property Manager

Contract
License Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations

CONFIDENTIAL TREATMENT REQUESTED. INFORMATION FOR WHICH CONFIDENTIAL TREATMENT HAS BEEN REQUESTED IS OMITTED AND MARKED WITH “[***]”. AN UNREDACTED VERSION OF THE DOCUMENT HAS ALSO BEEN FURNISHED SEPARATELY TO THE SECURITIES AND EXCHANGE COMMISSION AS REQUIRED BY RULE 406 UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

THE NATIONAL INSTITUTES OF HEALTH BIOLOGICAL MATERIALS LICENSE AGREEMENT
Biological Materials License Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations • District of Columbia

This Agreement is entered into between the National Institutes of Health (“NIH”) within the Department of Health and Human Services (“HHS”) through the Office of Technology Transfer, NIH, having an address at 6011 Executive Boulevard, Suite 325, Rockville, Maryland 20852-3804, U.S.A. and Hookipa Biotech AG (“Licensee”), a corporation of Vienna, Austria, having an office at Helmut-Qualtinger-Gasse 2, 1030 Vienna, Austria.

RENTAL AGREEMENT Partial scope Office
Rental Agreement • March 22nd, 2019 • HOOKIPA Pharma Inc. • Pharmaceutical preparations
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!